Key facts
- It has raised $280K across 2 recorded rounds; the latest was Seed Round ($251K) in Nov 2024.
- Notable investors include Hilton Finance.
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jabez Biosciences
Funding rounds
2 roundsAbout Jabez Biosciences
Developer of a cancer therapeutic designed to improve treatment outcomes while maintaining simplicity. The company offers a 3-S framework with oral delivery, low-cost manufacturing, and integration with existing therapies, enabling healthcare providers to offer tolerable and affordable cancer treatments.
- Sector
- Healthcare
- HQ
- Cranberry Township, PA, United States
- Founded
- 2024
- Employees
- 2
- Website
- jabezbio.com/
- Ownership
- Privately Held (backing)
Jabez Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jabez Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jabez Biosciences in its N-PORT filings yet. We sweep new filings monthly.